NDD Therapy area
Welcome to our NDD Community
A resource centre for healthcare professionals working in neurodevelopmental disorders such as attention deficit hyperactivity disorder, autism spectrum disorder, and learning disabilities.
NDD Pathways
Shape your learning with our carefully selected content.
Managing sleep in ASD patients aged 2-18
We work with leading experts in the field to design meeting programmes that explore key issues in ASD.
50% to 75% of children with neurodevelopmental or phychiatric comorbidities experience paediatric insomnia
Watch now our ‘Waking up to Children’s Insomnia – a Primary Care Perspective’ webinar. We were joined by Dr Jonathan Sunkersing, who discussed the challenges of treating paediatric sleep difficulties and the pharmacotherapy to improve outcomes.
Insomnia in Children with ASD: The Aetiological Role of Melatonin
Slenyto® (paediatric prolonged-release melatonin) for:
- treatment of insomnia in children and adolescents aged 2-18 years with Autism Spectrum Disorder (ASD), and/or neurogenetic disorders with aberrant diurnal melatonin secretion and/or nocturnal awakenings, where sleep hygiene measures have been insufficient
- treatment of insomnia in children and adolescents aged 6-17 years with attention-deficit hyperactivity disorder (ADHD) where sleep hygiene measures have been insufficient
- significant improvements, over baseline, in total sleep time, sleep initiation (latency) and maintenance, child behaviours (externalising), caregivers’ quality of life and resolution of caregiver sleep disturbance
Managing/Treating ADHD in patients aged 6-18
Flynn has been directly involved in the field of Attention Deficit Hyperactivity Disorder for over fourteen years
ADHD affects an estimated 3.6% of children and 2% of adults in the UK.
ADHD care changes across the lifespan — management needs to adapt and it is important for clinicians to be aware of the differences.
For patients and parents, developed as part of a joint collaboration between Flynn Pharma and Dr Chinnaiah Yemula, Consultant Paediatrician, Bedford.
An animation for young children with ADHD, this resource describes the human brain, its chemistry, ADHD symptoms and how medication for ADHD works.
Managing/Treating ADHD in adults
Despite its prevalence, ADHD in adults often goes unrecognised and remains under-diagnosed.
ADHD affects an estimated 3.6% of children and 2% of adults in the UK.
ADHD care changes across the lifespan — management needs to adapt and it is important for clinicians to be aware of the differences.
A training resource for psychiatrists to facilitate identification of adult ADHD. Flynn Pharma, in conjunction with Virtual Health Shed, has developed 3D characters in a virtual environment to simulate interaction between the learner and a virtual patient or clinical virtual actor (avatar).
Neurodevelopmental Disorders
Your site for therapy-specific events, resources and details of our products.
Events
Our online events and in-person study days include NDD, ASD, and ADHD . These can be viewed on the events page.
On-demand
Learn at your own pace with our on-demand events. These can be viewed in the resource library.
Resources
Free resources for HCPs and patient information across NDD. Searchable and categorised by therapy area, condition, format and products.
Products
Flynn supplies branded and generic medicines across a wide range of therapy areas including general medicine, gastroenterology, psychiatry, paediatrics, anti-infective medicine and emergency medicine.
Latest Events
We are committed to the delivery of high quality education and supporting the continued development of healthcare professionals — it's our way of helping you to help your patients. Here are the latest educational events across our therapy areas that are free for healthcare professionals to attend.
Clinical Decision-Making in Paediatric ADHD and Insomnia: Tools, Monitoring, and Case Discussions
This educational and promotional event is organised and funded by Flynn Pharma Ltd and Neurim Pharmaceuticals (1991) Ltd (Neurim). This meeting is intended for healthcare professionals only.
Join us for an insightful webinar where we will explore practical tools that assist with the identification and management of insomnia in busy daily practice and review patient cases with interactive audience participation.
Midlands Neurodevelopmental Disorders Nurse Forum
This educational and promotional event is organised and funded by Flynn Pharma Ltd. This meeting is for UK healthcare professionals only.
Join our guest speakers and learn how to recognise ADHD and co-occurring conditions and arrange timely assessment.
Underpinned by the Transforming Care Policy at local and national levels, speakers will explore complex trauma and how young people can be supported with evidence-based alternatives to psychiatric admission. Understand the impact of sleep disorders and how to navigate neurodivergent young women through developmental, emotional and social challenges.
Wales Neurodevelopmental Study Day
This educational and promotional event is organised and funded by Flynn Pharma Ltd. This meeting is intended for UK healthcare professionals only.
Join us for this in-person educational study day exploring ADHD and neurodevelopmental conditions across the lifespan. Expert speakers Dr Sunil Pulapaka, Dr Prathap Reddy, Dr Heidi Phillips, Sarah Idakwo and Dr Amani Hassan will discuss key topics including transition to adult services, learning difficulties, sleep, nutrition, ASD and Tourette syndrome.
Trending Resources
Flynn provides free resources for healthcare professionals and patient information across neurodevelopmental disorders.
Need more information or further support?
The leaflet considers the factors associated with poor sleep in children and adolescents with autism and provides tips and information on how to monitor sleep, how to take Slenyto and what to expect from treatment.
We work with leading experts in the field to design meeting programmes that explore key issues in ASD.
Watch our London Neurodevelopmental Disorders Study Day on demand now. We were joined by the following speakers: Dr Carsten Vogt, Dr Gayatri Omkar, Dr Moneesha Bhargava and Professor Raja Mukherjee. They discussed the treatment options available for the management of ADHD, the impact of COVID on ADHD assessments, looked at the range of approaches for effective management of sleep difficulties, and more.
A short story which provides some useful insight into ADHD in girls. The book aims to improve self-esteem and confidence.
A Guide for Parents: ADHD and ASD, Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder
Featured Contributors
